The suprachiasmatic nucleus (SCN), which appears to act as a circadian clock, contains a subpopulation of local circuit neurons in which vasoactive intestinal peptide (VIP), peptide histidine isoleucine (PHI), and gastrin releasing peptide (GRP) are colocalized.
To determine whether VIP, PHI, and GRP interact within the SCN to produce a signal important for circadian control, the behavioral and cellular effects of coadministration of these neuropeptides were investigated. Coadministration of VIP, PHI, and GRP within the SCN mimicked the phase-delaying effects of light on circadian control following in viva microinjection and activated SCN single units recorded in vitro. These behavioral and cellular effects of coadministration of VIP, PHI, and GRP were significantly greater than administration of VIP, PHI, or GRP alone or coadministration of any 2 of these peptides. These data illustrate a new mechanism whereby multiple, colocalized neuropeptides interact in a functionally significant manner, and indicate that the interaction of VIP, PHI, and GRP may be involved in the regulation of circadian rhythms by the SCN.
The colocalization of multiple neurotransmitters within the same neuron has been extensively documented in various regions of the CNS and PNS (Hokfelt et al., 1986) . Despite the abundance ofanatomical data demonstrating the coexistence of neurotransmitters, comparatively little is known about the functional consequences of neurotransmitter corelease. Studies in the PNS, however, have shown that coreleased neurotransmitters can interact to produce a signal different from that achieved by the release of either neurotransmitter alone. For example, vasoactive intestinal peptide (VIP) coreleased with ACh from parasympathetic neurons innervating the cat salivary gland potentiates the secretory activity of ACh, though VIP causes no secretion alone (Lundberg and Hokfelt, 1983) . It seems likely that coreleased neurotransmitters will interact in a variety of functionally significant ways, given the different classes ofchemical signals that have been colocalized and the widespread distribution of neurons containing more than 1 neurotransmitter.
In the hypothalamus, several variations have been observed in the molecular mechanisms producing colocalized peptides (Sofroniew et al., 1984) . In some cases, the colocalized peptides come from the same precursor, while in other cases, the colocalized peptides are derived from different precursors. One population of hypothalamic neurons in which both of these mechanisms appear to be active is in the suprachiasmatic nucleus (SCN). A large subpopulation of local circuit SCN neurons contains 2 peptides derived from the same precursor, VIP and peptide histidine isoleucine (PHI; Nishizawa et al., 1985) and has been more recently found to contain a third peptide derived from a different precursor, gastrin releasing peptide (GRP; Okamura et al., 1986) . The existence of GRP in VIP/PHI-immunoreactive neurons is also consistent with the distributions of GRP and VIP/PHI immunoreactivity and mRNA previously reported within the SCN (Card et al., 198 1, 1988; van den Pol and Tsujimoto, 1985; Stopa et al., 1988; Zoeller et al., 1989) .
A large body of evidence supports the view that the SCN acts as a circadian clock that both generates rhythms in behavior and physiology and synchronizes those rhythms with the environmental lightdark (LD) cycle (Meijer and Rietveld, 1989) . The SCN can be divided into several anatomically distinct subpopulations of intrinsic neurons (van den Pol, 1980; Moore and Card, 1985) , but it is not known how these neuronal subpopulations contribute to the generation and synchronization of circadian rhythms with the LD cycle. One hypothesis is that SCN neurons containing VIP/PHI are involved in mediating the effects of environmental lighting important in the synchronization ofcircadian rhythms with the LD cycle. This hypothesis is supported by the findings that environmental lighting selectively alters VIP and PHI immunoreactivity within the SCN (Albers et al., 1987) , and that the cellular levels of VIP/PHI mRNA vary over the day-night cycle (Stopa et al., 1988; Gozes et al., 1989; Albers et al., 1990) . The majority of VIP/PHIimmunoreactive neurons are contained within the ventrolateral SCN, which is also the site of termination of most SCN afferent pathways, including 2 well-defined photic projections, the retinohypothalamic tract (RHT) and the geniculohypothalamic tract (GHT) (Moore and Card, 1985) . The report that VIP, PHI, and GRP are colocalized in local circuit neurons in the afferent terminal fields of the SCN suggests that synchronization of circadian rhythms with the LD cycle may depend on the corelease of these 3 peptides. If so, the combined effect of VIP, PHI, and GRP on circadian rhythms should be different from the effects of each peptide given either alone or in combination with 1 of the other 2 peptides. The purpose of the present study was to verify the colocalization of VIP/PHI and GRP mRNA in SCN neurons using in situ hybridization, and to investigate the functional consequences of VIP, PHI, and GRP colocalization in the control of circadian rhythms by SCN neurons at the behavioral and cellular levels.
Materials and Methods
the recording session, a current of 5 PA was passed through the electrode in the integrated records obtained from a chart recorder by calculating for 3-5 min to deoosit a blue snot. All recordina sites used in the present the change in firing rate from the resting level (mean firing rate during the 5 min prior to drug application) to the peak level (mean firing rate during 1 min). Peptide-containing medium reached the recording chamber 2-3 min after the switch from incubation medium. At the end of In situ hybridization. Rats housed under an LD 14: 10 cycle for at least 2 weeks were killed by decapitation. Coronal sections (12 rm) through the male rat SCN were made on a cryostat; each section was thaw mounted onto a separate gelatin-coated slide. The steps used for in situ hybridization have been reported previously (Zoeller et al., 1989) . In brief. sections were warmed to room temperature. immersed in 4% study were in the'ventrolateral SCN, where the VIP-, PHI-, and GRPimmunoreactive neurons are primarily located.
Results
formaldehyde/phosphate-buffered saline (PBS) for 5 min, rinsed in PBS, and soaked for 10 r&n in 0.25% acetic anhydride in 0.1 M triethanolamine hydrochloride/0.9% NaCl (pH, 8.0). After rinsing in 2 x S SC (300 mM NaCV30 mM sodium citrate), sections were dehydrated through a graded series of ethanol, delipidated in chloroform, rehydrated to 95% ethanol. and air dried. The hvbridization buffer contained 50% formamide, 4 x SSC, transfer RNA (250 &ml) sheared single-stranded salmon sperm DNA (100 &ml), 1 x Denhardt's solution (0.02% each of BSA, Ficoll, and polyvinylpyrrolidone), 10% (w/v) dextran sulfate (MW, SOO,OOO), 100 mM dithiothreitol (DDT), and 0.75 x lo6 cpm probe. Fifty microliters of hybridization buffer was applied to each slide, which was then covered with a parafilm coverslip and incubated at 37°C for 20 hr in humid chambers. Following hybridization, the coverslips were floated off in 1 x SSC and washed 2 times in 1 x SSC, then washed 4 times for 15 min each in 2 x SSC/SO% formamide at 40°C. After 2 30-min washes in 1 x SSC at room temperature, the slides were dipped in distilled water, equilibrated in 70% ethanol, and air dried.
The 48-base oligonucleotides were 3' end labeled using terminal deoxynucleotidyl transferase. The base sequence for VIP/PHI (ATGGA-GTTCAAGTATTTCTTCACAGCCATTTGCTTTCTAAGGCGGGT) corresponds to base numbers 403449 (see Nishizawa et al., 1985) . The base seauence for GRP (CCCTTCAGCTGGCAGTTCCTTCCTTCCC-CTTGAGAACCTGGAGCAGAG) corresponds to the sequence used previously to map the distribution of GRP mRNA in the rat brain (Zoeller et al., 1989). examined in rats by comparison of VIP/PHI and GRP mRNA
The colocalization of VIP/PHI and GRP in SCN neurons was within neurons of the ventrolateral SCN using in situ hybridization. As expected, the autoradiographic signal produced by probes complementary to rat VIP/PHI and GRP mRNAs was restricted to the ventrolateral aspect of the SCN. Analysis of adjacent sections labeled separately for VIP/PHI mRNA or GRP mRNA indicated that GRP mRNA and VIP/PHI mRNA could be found in the same SCN neuron (Fig. 1) . It was not possible to estimate the proportion of VIP/PHI neurons containing GRP because the section thickness (12 pm) was greater than the average diameter of nuclei in SCN neurons (i.e., 6.5 1 ? 0.8 pm); thus, not all nuclei were contained within both sections. However, because the low abundance of GRP mRNA requires severa1 weeks of exposure to detect the signal, thinner sections would have compromised the ability to detect GRP mRNA in single cells. The long exposure time necessary for the detection of GRP mRNA suggests that the mRNA encoding GRP is expressed less abundantly than VIP/PHI mRNA.
Microinjection experiments. Hamsters were used for behavioral studies examining the interaction of VIP, PHI, and GRP because of the precise nature of their wheel-running rhythm and because the anatomy of the rat and hamster are very similar (Card and Moore, 1984) . Hamsters were deeply anesthetized with sodium pentobarbital and stereotaxically implanted with 26-gauge guide cannulas aimed at the suprachiasmatic region. The stereotaxic coordinates were 1.6 mm anterior and 1.7 mm lateral to bregma, and -7.7 mm below dura. The incisor bar was set at 0, and the stereotaxic arm was set 10" from perpendicular. Following surgery, each hamster was placed in a cage containing an activity wheel in a room maintained under continuous illumination (700-1000 lux). After a stable free-running activity rhythm was established, peptides were microinjected into the SCN region at 7-10-d intervals. Pentides were dissolved in 0.9% NaCl (saline) and injected with a 1 -Al Hamilton syringe connected to a 33-gauge needle by polyethylene tubing. Peptides were purchased from Bachem, Inc., Torrance, CA. A cocktail containing approximately equimolar concentrations of VIP, PHI, and GRP was made by dissolving approximately 50 pmol VIP, 50 pmol PHI, and 50 pmol GRP into 400 nl saline. In all protocols, a total of I50 pmol peptide was injected in 400 nl saline. Following the experiment, hamsters were deeply anesthetized with sodium pentobarbital and microinjected with 400 nl of dye. Following intracardial perfusion with Perfix (Fisher Scientific), the brain was removed and examined to verify the site of injection. Phase shifts in the activity rhythm were calculated by linear regression using the method of Daan and Pittendrigh (1976) .
Hypothalamic slice experiments. Extracellular single-unit recordings were made from SCN slices harvested from hamsters housed in an LD 14: 10 cycle using procedures reported previously (Liou and Albers, 1989) . In brief. coronal brain slices 400-450 urn in thickness were cut on a vibratome and placed in incubation medium oxygenated with 95% 0, and 5% CO, at 35'C for 1 hr. Slices were then-transferred to the recording chamber, where extracellular recordings were made using glass micropipettes with DC resistances of 2540 MO filled with 0.5 M sodium acetate containing 2% fast green. Repeated experiments were conducted on the same unit onlv if the firma rate returned to baseline after the washout period. The responses to application of peptides were assessed Because these and other data (Okamura et al., 1986) indicate that VIP, PHI, and GRP are colocalized within a subpopulation of SCN neurons, the circadian effects of coadministration of these peptides on the timing of circadian rhythms were examined in hamsters. As can be seen in Figure 1 , microinjection of VIP/PHI/GRP produced large phase delays in the timing of the circadian activity rhythm when administered around the time of the onset of the daily active phase, but not at other times within the circadian cycle. The phase shifts produced by microinjection of VIP/PHI/GRP throughout the circadian cycle (N = 39) are summarized in Figure 2 . The magnitude of the phase shifts produced by VIP/PHI/GRP differed significantly (p < 0.05) depending on time of administration within the circadian cycle. No corresponding differences @ > 0.05) were observed in the effects of VIP/PHI/GRP on the free-running circadian period over the circadian cycle. Comparison of the effects of VIP/PHI/GRP on circadian timing with the well-known phase-shifting effects of brief light pulses (Daan and Pittendrigh, 1976) revealed that VIP/PHI/GRP mimicked the phase-delaying, but not the phase-advancing, effects of light.
To investigate whether the phase delays produced by VIP/ PHI/GRP were the result of their action within the SCN region, or whether these peptides may have acted in CNS regions other than the SCN after entering the ventricular system, the effects ofVIP/PHI/GRP microinjection into the SCN region were compared with microinjections given directly into the lateral ventricle. VIP/PHI/GRP administered into the lateral ventricle during the 3-hr interval following the onset of activity (i.e., circadian time 12-l 5) produced a mean (?SEM) phase shift of 0.04 -t 0.13 hr (N = 8) , which differed significantly @ < 0.0 1) from the 1.53 f 0.35 (N = 11) phase delay produced by VIP/ PHI/GRP microinjected into the SCN region. These data there- fore support the view that the phase-shifting effects of VIP/PHI/ GRP result from their influence on SCN neurons.
Although VIP/PHI/GRP coexist within a subpopulation of SCN neurons, it is not known whether an interaction between all 3 peptides is required to mimic the phase-delaying effects of light, or if 1 or 2 of these peptides is sufficient to phase delay circadian rhythms. To investigate the potential significance of the interaction among VIP, PHI, and GRP within the SCN, the phase-shifting effects of administration of VIP, PHI, and GRP and the coadministration of VIP/PHI, VIP/GRP, and PHI/GRP were compared with the coadministration of VIP/PHI/GRP. In each injection, the total amount of peptide (150 pmol) given was identical (e.g., the VIP injections contained 150 pmol of VIP, and the VIP/PHI/GRP injections contained 50 pmol VIP, 50 pmol PHI, and 50 pmol GRP). A statistically significant (p < 0.05) difference was observed in the magnitude of the phase delays produced by the various combinations of the 3 peptides (Fig. 3) , but no corresponding differences (p > 0.05) were observed in the free-running circadian period. Administration of VIP, PHI, or GRP alone phase delayed the activity rhythm by 30 min or less. Although coadministration of 2 of the 3 peptides produced slightly larger phase delays than when given alone, the phase delays produced by coadministration of 2 peptides remained at least 50% less than those produced by coadministration of VIP/PHI/GRP.
The next series of experiments used the hypothalamic slice preparation and examined the cellular effects of VIP, PHI, and GRP and their coadministration on SCN neurons. The spontaneous firing of neurons in the ventrolateral SCN was recorded extracellularly during an 8-hr interval beginning at the phase of the circadian cycle corresponding to 4 hr before the time that locomotor activity normally begins (i.e., circadian time 8-16). Coadministration of VIP/PHI/GRP into the perfusate increased the firing rate by an average of 3.85 f 0.35 impulses/set in 65% of the 23 neurons examined. In contrast, coadministration of any 2 of the peptides, or VIP, PHI, or GRP alone, in the same molar concentration (i.e., lo-'), produced significantly less excitation than did coadministration of VIP/PHI/GRP (Figs. 4,   5 ). The excitation of SCN neurons produced by peptide coadministration was dose dependent (Fig. 6 ).
Discussion
The coadministration of VIP/PHI/GRP is necessary for the full expression of the cellular and behavioral effects of these pcptides within the SCN. VIP, PHI, or GRP, or any combination of 2 of these peptides, did not produce phase delays or an increase in single-unit discharge of the magnitude produced by combined administration of all 3 peptides. Furthermore, there was no evidence that any one of these peptides represents the primary signal of the VIP/PHI/GRP SCN neurons, because no differences were observed in the effects of these peptides when given alone or in combination with one of the other peptides. These observations suggest that VIP, PHI, and GRP interact within the SCN by a mechanism that is different from that previously reported for other colocalized messengers, where one neurotransmitter usually constitutes the primary signal, while the other messenger modifies that signal but has little or no activity alone (Hokfelt et al., 1986) .
The present findings provide strong evidence for the localization of specific circadian functions to a subpopulation of intrinsic SCN neurons. The ability of VIP/PHI/GRP to mimic the phase-delaying effects of light on circadian rhythms within the SCN supports the hypothesis that the neurons that contain these neuropeptides are involved in the synchronization of circadian rhythms by the LD cycle. VIP/PHI/GRP-containing neurons may also integrate more than just photic input to the SCN because photic as well as nonphotic projections terminate directly on VIP-immunoreactive SCN neurons (Kiss et al., 1984; Bosler and Beaudet, 1985; Ibata et al., 1987) .
One hypothesis for how VIP/PHI/GRP SCN neurons integrate afferent information is that the availability of the 3 peptides within SCN neurons is differentially regulated by afferent input. If so, the ratio of the peptides available for release would be altered depending on the specific type of afferent information received. Other data indicate that afferent neuronal activity can inlluence the expression of specific neurosecretory products (Ei-TIME OF DAY ( den Friedman et al., 1988) . Furthermore, cellular levels of VIP/PHI mRNA are not constant within the SCN but vary such that greater concentrations occur at night than during the day (Stopa et al., 1988; Gozes et al., 1989; Albers et al., 1990) . Interestingly, cellular levels of GRP mRNA within the SCN also change over the day, but in a pattern distinctly different from that of VIP/PHI mRNA . Collectively, these data indicate that availability of these peptides may be differentially regulated, and, as a result, the ratio of VIP/PHI to GRP released within the SCN might change as a function of time of day and/or afferent input. The results of the present study suggest that, if the changes in the ratios of VIP, PHI, and GRP are sufficiently large, the resulting circadian effects (e.g., magnitude of phase delay) produced by the endogenously released neuropeptide cocktail may be correspondingly altered.
It is not known why the coadministration of VIP/PHI/GRP mimics the phase-delaying but not the phase-advancing effects of light pulses. One possibility is that phase advances and phase t to the time of activity onset). VIP/PHVGRP produced phase-delay shifts around the time of activity onset, but had no effect at other times within the circadian cycle. VIP/PHI/GRP microinjection mimics the phase-delaying but not the phase-advancing effects of brief light pulses (Daan and Pittendrigh, 1976) . Figure 4 . Summary of the behavioral and cellular effects of administration of VIP, PHI, and GRP alone, coadministration of 2 of these peptides (i.e., VIP/PHI, VIP/GRP, and PHUGRP), and coadministration of all 3 peptides (VIP/PHI/GRP).
TOP, Phase shifts produced in hamster wheel-running rhythms following peptide microinjection into the suprachiasmatic region given in the 3 hr following activity onset (i.e., circadian time 12-15). One-way ANOVA revealed a significant difference @ < 0.05) in the magnitude of phase delays between the groups. Post hoc comparisons subsequent to the ANOVA revealed statistically significant (p < 0.05) differences between the VIP/PHI/GRP group and the VIP, PHI, GRP, VIP/PHI, and VIP/GRPgroups. A priori comparisons indicated a statistically significant (p < 0.05) difference between the VIP/PHI/GRP group and the VIP + PHI + GRP groups and between the VIP/PHI/GRP group and the VIP/PHI + VIP/GRP + PHI/GRP groups. All statistics were calculated using SPSSx. 
